Pharma-Bio Serv (PBSV) Invested Capital (2019 - 2024)

Pharma-Bio Serv (PBSV) has reported Invested Capital for 5 consecutive years, with $15.9 million the latest figure, recorded in Q1 2024.

• For the quarter ending Q1 2024, Invested Capital changed N/A year-over-year to $15.9 million; the trailing twelve-month figure through Jan 2024 stood at $15.9 million (changed N/A YoY), and the FY2023 full-year result was $16.1 million, changed N/A from the prior year.
• Invested Capital declined to $15.9 million in Q1 2024 per PBSV's latest filing, from $16.1 million in the prior quarter.
• Across five years, Invested Capital topped out at $24.6 million in Q4 2020 and bottomed at $15.9 million in Q1 2024.
• Historically, Invested Capital has averaged $21.6 million across 4 years, with a median of $23.5 million in 2021.
• The sharpest annual moves came in 2020 and 2021: Invested Capital grew 19.61% in 2020, then retreated 23.26% in 2021.
• Over 4 years, Invested Capital stood at $24.6 million in 2020, then declined by 23.26% to $18.9 million in 2021, then declined by 14.74% to $16.1 million in 2023, then declined by 1.54% to $15.9 million in 2024.
• According to Business Quant data, Invested Capital over the past three periods registered $15.9 million, $16.1 million, and $18.9 million for Q1 2024, Q4 2023, and Q4 2021 respectively.